Sensus Healthcare to Participate in the H.C. Wainwright Global Investment Conference
May 18 2022 - 4:05PM
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device
company specializing in highly effective, non-invasive, minimally
invasive and cost-effective treatments for oncological and
non-oncological conditions, announces that management will be
participating in the H.C. Wainwright Global Investment Conference
taking place virtually and in-person at the Fontainebleau Miami
Beach May 23-26, 2022.
Sensus management will deliver a corporate
presentation on May 25 at 9:30 a.m. Eastern time, and the live and
archived presentation will be available on the Company’s website
here. In addition, Michael Sardano, president and general
counsel, and Javier Rampolla, chief financial officer, will be
holding one-on-one meetings with the investment community both
virtually and in-person at the conference.
About Sensus Healthcare
Sensus Healthcare, Inc. is a medical device
company specializing in highly effective, non-invasive,
minimally-invasive and cost-effective treatments for both
oncological and non-oncological conditions. Sensus offers its
proprietary low-energy X-ray technology known as superficial
radiation therapy (SRT), which is the culmination of more than a
decade of research and development, to treat non-melanoma skin
cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100
Vision™ systems. With its portfolio of innovative medical device
products, including aesthetic lasers and its needleless TransDermal
Infusion System™, Sensus provides revolutionary treatment options
to enhance the quality of life of patients around the world.
For more information, visit
www.sensushealthcare.com.
Contact: LHA Investor Relations Kim
Sutton Golodetz212-838-3777kgolodetz@lhai.com
# # #
Sensus Healthcare (NASDAQ:SRTS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sensus Healthcare (NASDAQ:SRTS)
Historical Stock Chart
From Apr 2023 to Apr 2024